[go: up one dir, main page]

SG11202008791UA - Agent for prevention and/or treatment of pseudomonas aeruginosa infection - Google Patents

Agent for prevention and/or treatment of pseudomonas aeruginosa infection

Info

Publication number
SG11202008791UA
SG11202008791UA SG11202008791UA SG11202008791UA SG11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA
Authority
SG
Singapore
Prior art keywords
prevention
agent
treatment
pseudomonas aeruginosa
aeruginosa infection
Prior art date
Application number
SG11202008791UA
Inventor
Susumu Kawaguchi
Miho Kato
Original Assignee
Nutri Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Co Ltd filed Critical Nutri Co Ltd
Publication of SG11202008791UA publication Critical patent/SG11202008791UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202008791UA 2018-04-19 2019-04-17 Agent for prevention and/or treatment of pseudomonas aeruginosa infection SG11202008791UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018080756 2018-04-19
PCT/JP2019/016441 WO2019203260A1 (en) 2018-04-19 2019-04-17 Agent for prevention and/or treatment of pseudomonas aeruginosa infection

Publications (1)

Publication Number Publication Date
SG11202008791UA true SG11202008791UA (en) 2020-11-27

Family

ID=68238941

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008791UA SG11202008791UA (en) 2018-04-19 2019-04-17 Agent for prevention and/or treatment of pseudomonas aeruginosa infection

Country Status (9)

Country Link
US (1) US12053496B2 (en)
EP (1) EP3782631A4 (en)
JP (1) JP7296369B2 (en)
KR (1) KR102681178B1 (en)
CN (1) CN111867607A (en)
AU (1) AU2019257028A1 (en)
CA (1) CA3096433A1 (en)
SG (1) SG11202008791UA (en)
WO (1) WO2019203260A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023026957A1 (en) * 2021-08-27 2023-03-02 ニュートリー株式会社 Agent for prevention and/or treatment of porphyromonas gingivalis infection
CN115090225A (en) * 2022-05-12 2022-09-23 重庆中科力泰高分子材料股份有限公司 Novel efficient aldehyde-removing transparent gel and preparation method thereof
KR20240033466A (en) 2022-09-05 2024-03-12 국립부경대학교 산학협력단 System and method for analyzing atmospheric environments of urban area

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283166A (en) * 1995-04-12 1996-10-29 Nichinichi Seiyaku Kk Prophylactic agent
JP2002179580A (en) 2000-12-13 2002-06-26 Zenwa Gu Medicament containing propolis extract, royal jelly, and killed enterococcus faecalis
SG93936A1 (en) 2001-05-21 2003-01-21 Combi Co Infection-preventing composition, and food or drink containing the same
JP2003261453A (en) 2002-03-11 2003-09-16 Nippon Berumu Kk Antitumor agent and radiation-protecting agent consisting of e. faecalis
US20090098520A1 (en) * 2007-10-13 2009-04-16 Aaron Wilson Dressage flexion and extension training device and method
CN101938992B (en) * 2008-02-06 2013-07-10 东英吉利大学 Composition and method for assisting swallowing
CN103502434B (en) 2011-05-06 2016-08-17 有机平衡医疗股份公司 Lactic acid bacteria and the compositions containing this lactic acid bacteria
CN103751223A (en) * 2011-10-17 2014-04-30 陈双露 Infection-suppressing composition, and food containing the same
US20190053527A1 (en) * 2015-09-21 2019-02-21 Institut National De La Recherche, Agronomique (Inra) Method for preparing a probiotic powder using a two-in-one whey-containing nutrient medium
JP2018080756A (en) 2016-11-16 2018-05-24 日本精工株式会社 Rolling bearing with seal

Also Published As

Publication number Publication date
AU2019257028A1 (en) 2020-10-01
CA3096433A1 (en) 2019-10-24
JPWO2019203260A1 (en) 2021-04-30
WO2019203260A1 (en) 2019-10-24
JP7296369B2 (en) 2023-06-22
EP3782631A1 (en) 2021-02-24
CN111867607A (en) 2020-10-30
EP3782631A4 (en) 2022-01-05
KR20210002461A (en) 2021-01-08
US20200405784A1 (en) 2020-12-31
US12053496B2 (en) 2024-08-06
KR102681178B1 (en) 2024-07-04

Similar Documents

Publication Publication Date Title
IL277473B2 (en) Treatment and prevention of microbial infections
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
EP3294761A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PARE INFECTION. COLI
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
IL270976A (en) Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections
EP3632431A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF CEREBRAL ATROPHY
SG11202008791UA (en) Agent for prevention and/or treatment of pseudomonas aeruginosa infection
HUE058250T2 (en) Medicament for prevention or treatment of rhinovirus infection
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
ZA202000558B (en) Prevention and/or treatment of neurodegenerative disease
EP4041275A4 (en) Treatment and prevention of nephrotoxin-induced kidney injuries
PT4031117T (en) Agent for use in treatment or prevention of ophthalmic disorders
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
GB201704688D0 (en) Calcicum based clinical material with antimicrobial properties and method of forming for prevention or treatment of infection
EP3789019A4 (en) Composition for prevention or treatment of skin infection
ZA201808182B (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
EP3525771A4 (en) Prevention and/or treatment of contrast-induced acute kidney injury
EP3811958A4 (en) Composition for the prevention and/or treatment of haemorrhoids
SI3737378T1 (en) Palonosetron eye drops for the treatment or prevention of nausea and vomiting
HK40112570A (en) Prevention and/or treatment of contrast-induced acute kidney injury
PT3829535T (en) Compositions for the prevention and treatment of cutaneous affections
EP3967300C0 (en) Composition for the prevention and treatment of infections and/or inflammations
HK40101696A (en) Treatment and prevention of nephrotoxin-induced kidney injuries
GB202210704D0 (en) Biofilm prevention and treatment